IL75733A - 5-phenyl-1,6-naphthyridin-2(1h)-ones,their preparation and pharmaceutical compositions containing them - Google Patents

5-phenyl-1,6-naphthyridin-2(1h)-ones,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL75733A
IL75733A IL75733A IL7573385A IL75733A IL 75733 A IL75733 A IL 75733A IL 75733 A IL75733 A IL 75733A IL 7573385 A IL7573385 A IL 7573385A IL 75733 A IL75733 A IL 75733A
Authority
IL
Israel
Prior art keywords
naphthyridin
ones
phenyl
preparation
pharmaceutical compositions
Prior art date
Application number
IL75733A
Other languages
English (en)
Other versions
IL75733A0 (en
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of IL75733A0 publication Critical patent/IL75733A0/xx
Publication of IL75733A publication Critical patent/IL75733A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL75733A 1984-07-13 1985-07-05 5-phenyl-1,6-naphthyridin-2(1h)-ones,their preparation and pharmaceutical compositions containing them IL75733A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/630,810 US4560691A (en) 1984-07-13 1984-07-13 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation

Publications (2)

Publication Number Publication Date
IL75733A0 IL75733A0 (en) 1985-11-29
IL75733A true IL75733A (en) 1988-07-31

Family

ID=24528649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL75733A IL75733A (en) 1984-07-13 1985-07-05 5-phenyl-1,6-naphthyridin-2(1h)-ones,their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US4560691A (es)
EP (1) EP0168037B1 (es)
JP (1) JPS6140286A (es)
KR (1) KR870001089B1 (es)
AR (1) AR242388A1 (es)
AT (1) ATE50259T1 (es)
AU (1) AU584103B2 (es)
DE (1) DE3575926D1 (es)
DK (1) DK318985A (es)
ES (1) ES8706151A1 (es)
FI (1) FI852765L (es)
GR (1) GR851677B (es)
IL (1) IL75733A (es)
MX (1) MX161361A (es)
NO (1) NO852677L (es)
NZ (1) NZ212647A (es)
PH (1) PH21844A (es)
PT (1) PT80809B (es)
ZA (1) ZA855280B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532247A (en) * 1983-08-08 1985-07-30 Sterling Drug Inc. 5-(Hydroxyalkyl or alkanoyloxymethyl)-1,6-naphthyridin-2(1H)-one and cardiotonic use thereof
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
NZ214837A (en) * 1985-01-28 1988-10-28 Sterling Drug Inc 5-substituted 1,6 naphthyridin-2(1h)-ones
DE3840341A1 (de) * 1988-11-30 1990-06-07 Basf Ag Verfahren zur herstellung von 1-nitroanthrachinon-2-carbonsaeure
US7235551B2 (en) * 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
JP4524072B2 (ja) * 2000-10-23 2010-08-11 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規化合物
DE60315826T2 (de) * 2002-04-19 2008-05-21 Smithkline Beecham Corp. Neue verbindungen
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
KR20080002865A (ko) * 2005-03-25 2008-01-04 글락소 그룹 리미티드 피리도[2,3-d]피리미딘-7-온 및3,4-디히드로피리미도[4,5-d]피리미딘-2(1h)-온유도체의 제조 방법
US20090137550A1 (en) * 2005-03-25 2009-05-28 Glaxo Group Limited Novel Compounds
TW200724142A (en) * 2005-03-25 2007-07-01 Glaxo Group Ltd Novel compounds
PE20061351A1 (es) 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
CN105218388B (zh) * 2015-10-26 2017-07-11 西北农林科技大学 β‑羰基烯胺类化合物及作为制备植物病原菌抗菌剂的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4412077A (en) * 1982-03-15 1983-10-25 Sterling Drug Inc. Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone
US4415580A (en) * 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same

Also Published As

Publication number Publication date
DE3575926D1 (de) 1990-03-15
EP0168037A2 (en) 1986-01-15
AU4474785A (en) 1986-01-16
FI852765L (fi) 1986-01-14
ATE50259T1 (de) 1990-02-15
JPS6140286A (ja) 1986-02-26
EP0168037B1 (en) 1990-02-07
AU584103B2 (en) 1989-05-18
US4560691A (en) 1985-12-24
ES8706151A1 (es) 1987-06-01
ZA855280B (en) 1986-02-26
KR870001089B1 (ko) 1987-06-04
PH21844A (en) 1988-03-17
NO852677L (no) 1986-01-14
AR242388A1 (es) 1993-03-31
PT80809A (en) 1985-08-01
NZ212647A (en) 1988-07-28
FI852765A0 (fi) 1985-07-12
MX161361A (es) 1990-09-18
DK318985D0 (da) 1985-07-12
ES545139A0 (es) 1987-06-01
DK318985A (da) 1986-01-14
PT80809B (en) 1987-01-12
GR851677B (es) 1985-11-26
KR860001109A (ko) 1986-02-22
IL75733A0 (en) 1985-11-29
EP0168037A3 (en) 1986-03-26

Similar Documents

Publication Publication Date Title
IL78079A0 (en) Sulphonylaminoethyl compounds,their preparation and pharmaceutical compositions containing them
IL76133A0 (en) Bicyclic compounds,their preparation and pharmaceutical compositions containing them
IL75147A0 (en) Pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL78804A (en) N-benzhydrylpiperazinealkananilides,their preparation and pharmaceutical antianaphylactic and antibronchospastic compositions containing them
IL76020A0 (en) 3-acylaminomethylimidazo(1,2-a)pyridine derivatives,their preparation and pharmaceutical compositions containing them
IL75621A0 (en) Substituted benzamides,their preparation and pharmaceutical compositions containing them
IL74244A (en) Quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL75733A (en) 5-phenyl-1,6-naphthyridin-2(1h)-ones,their preparation and pharmaceutical compositions containing them
IL75219A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them
IL75966A0 (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
IL75720A0 (en) Morpholinol compounds,their preparation and pharmaceutical compositions containing them
IL71648A (en) 5-acyl-2-(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
IL76312A (en) Xenocoumacins and derivatives thereof,their preparation and pharmaceutical compositions containing them
EP0159652A3 (en) 4-phenylphthalazine derivatives, their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
DE3561808D1 (en) Phenylnonatetraenic-acid derivatives, their preparation and pharmaceutical compositions containing them
IL75636A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
IL78957A0 (en) 11-beta substituted steroids,their preparation and pharmaceutical compositions containing them
IL74006A0 (en) Tricyclic compounds,their preparation and pharmaceutical compositions containing them
IL75775A0 (en) Aminoeburnanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75776A0 (en) Nitroapovincaminic acid derivatives,their preparation and pharmaceutical compositions containing them
IL75632A0 (en) Furo-or pyrrolo-pyridine compounds,their preparation and pharmaceutical compositions containing them
IL78687A0 (en) Acylaminomethyl-penem compounds,their preparation and pharmaceutical compositions containing them
DE3570667D1 (en) 3-aminopropyloxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
IL72555A (en) 5-substituted-1,6-naphthyridin-2(1h)-one derivatives,their preparation,pharmaceutical compositions containing them and intermediates therefor